Rashad N, Abdelhamid T, Shouman SA, Nassar H, et al. Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study. Clin Breast Cancer 2020 Jan 7. pii: S1526-8209(20)30002.
PMID: 32005499